Microdosing: A Powder-in-Capsule Technology Pathway from Development to Commercialization

Published on: 


Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT

Microdosing is one way in which a drug’s path to market can be accelerated by providing flexibility in dosage sizes. This webinar will explore how Lonza approaches a powder-in-capsule development campaign.

Register Free: https://www.pharmtech.com/pt_w/development-to-commercialization

Event Overview:

Microdosing can accelerate the journey of a drug product from early development through to commercialization. This webcast will look at the principles of microdosing and how Lonza goes about filling drug substance directly into a capsule using equipment such as the Xcelodose 600 or 600S, as well as the Harro Höfliger Modu-C Mid Speed Encapsulator. The two systems provide the flexibility to manufacture powder-in-capsule dosages in multiple strengths with rapid and accurate filling parameters.

Key Learning Objectives:

  • Learn about powder-in-capsule development design and how the approach can be used to accelerate clinical trial supply.
  • Discover how the Harro Höfliger Modu-C can be used to scale up from clinical to commercial manufacturing.
  • Find out operational details and the benefits of the equipment.

Who Should Attend

  • Pharmaceutical Industry Directors
  • Principal Investigators/CMC Leads
  • Manufacturing and Development Engineers


Mark Cappucci
Preformulation Team Lead
Lonza Small Molecules

Mark Cappucci serves as the Preformulation Team Lead at Lonza’s site in Tampa, Florida, USA. He has more than 26 years of experience in the pharmaceutical industry with expertise in areas including drug substance characterization, polymorph identification, and microdosing techniques using Lonza’s Xcelodose® system. Mark joined Lonza in 2004, after working for Amgen and Bausch & Lomb in positions of increasing authority. He received his BS in Chemistry from The Ohio State University.

Benito G. Graniela
MSAT Engineer II
Lonza Small Molecules

Benito Graniela is an MSAT Engineer II at Lonza's site in Tampa, Florida, USA. He has more than 6 years of experience in the pharmaceutical industry with expertise in areas including process development, scale-up, investigation root cause analysis, and lean manufacturing. Benito joined Lonza Tampa in 2021 and received his BS in Chemical Engineering from the University of Florida.

Register Free: https://www.pharmtech.com/pt_w/development-to-commercialization